Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Mar 16, 2012 at 7:15 AM EDT

SciClone Raising Capital (SCLN)

SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) has filed to raise capital, some for the company and some for its existing shareholders.…

Douglas A. McIntyre | Mar 15, 2012 at 6:36 AM EDT

States Where Seniors Cannot Afford to Live

The average older American living independently does not have the means to meet basic standards of living, according to a…

Douglas A. McIntyre | Mar 9, 2012 at 6:22 AM EST

Alzheimer’s and the Economy

Many of the medical costs that Congress has begun to battle can be controlled. There is an argument this includes the…

Douglas A. McIntyre | Mar 7, 2012 at 6:32 AM EST

Price of Drugs for the Elderly Soars

The AARP put out a remarkably complex research paper that shows, among other things, that the costs that people over…

Douglas A. McIntyre | Mar 5, 2012 at 6:36 AM EST

The $28,000 Appendectomy

An organization called the International Federation of Health Plans keeps track of medical costs in most of the developed nations…

Jon C. Ogg | Feb 22, 2012 at 4:36 PM EST

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday. The FDA panel reviewing its Qnexa drug…

Jon C. Ogg | Feb 17, 2012 at 7:22 AM EST

Crushing Blow for Gilead, Billions of Dollars (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) is being crushed after a disappointing result in its Hepatitis C treatment after reporting that…

Douglas A. McIntyre | Feb 7, 2012 at 6:51 AM EST

Walmart Decides to Cut Sales of Unhealthy Foods

Instead of admitting that it has, in the past, sold food with too much sodium, salt and sugar, Walmart (NYSE:…

Jon C. Ogg | Feb 2, 2012 at 8:55 AM EST

Merck Close to 52-Week High After Earnings (MRK)

Merck & Company, Inc. (NYSE: MRK) is trading up after its earnings report. With a high dividend yield of 4.4%,…

Jon C. Ogg | Jan 31, 2012 at 7:17 AM EST

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s…

Jon C. Ogg | Jan 27, 2012 at 5:31 PM EST

FTC Sues To Block Omnicare/PharMerica Merger; Express/Medco Next? (OCR, PMC, MHS, ESRX, T)

The Federal Trade Commission is suing to block the merger between Omnicare, Inc. (NYSE: OCR) and Pharmerica Corporation (NYSE: PMC), where…

Jon C. Ogg | Jan 26, 2012 at 5:08 PM EST

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN)…

Jon C. Ogg | Jan 19, 2012 at 3:04 PM EST

Risks Abound In Express Scripts & Medco Merger (MHS, ESRX, T, CHSI, MNA)

The Medco Health Solutions Inc. (NYSE: MHS) and Express Scripts Inc. (NASDAQ: ESRX) merger saga is one which may go…

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Jon C. Ogg | Jan 10, 2012 at 11:47 AM EST

The $1,000 Genome Finally Arrives (LIFE)

Personalized medicine is coming… if you can afford it. The quest for the $1,000 genomic map has been a race and…

1 … 322 323 324 325 326 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

SciClone Raising Capital (SCLN)

States Where Seniors Cannot Afford to Live

Alzheimer’s and the Economy

Price of Drugs for the Elderly Soars

The $28,000 Appendectomy

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

Crushing Blow for Gilead, Billions of Dollars (GILD)

Walmart Decides to Cut Sales of Unhealthy Foods

Merck Close to 52-Week High After Earnings (MRK)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

FTC Sues To Block Omnicare/PharMerica Merger; Express/Medco Next? (OCR, PMC, MHS, ESRX, T)

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

Risks Abound In Express Scripts & Medco Merger (MHS, ESRX, T, CHSI, MNA)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The $1,000 Genome Finally Arrives (LIFE)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

SciClone Raising Capital (SCLN)

States Where Seniors Cannot Afford to Live

Alzheimer’s and the Economy

Price of Drugs for the Elderly Soars

The $28,000 Appendectomy

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

Crushing Blow for Gilead, Billions of Dollars (GILD)

Walmart Decides to Cut Sales of Unhealthy Foods

Merck Close to 52-Week High After Earnings (MRK)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

FTC Sues To Block Omnicare/PharMerica Merger; Express/Medco Next? (OCR, PMC, MHS, ESRX, T)

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)

Risks Abound In Express Scripts & Medco Merger (MHS, ESRX, T, CHSI, MNA)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The $1,000 Genome Finally Arrives (LIFE)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation